Raymond James Financial Inc. Buys Shares of 5,400 Cytokinetics, Incorporated (NASDAQ:CYTK)
Raymond James Financial Inc. purchased a new position in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 5,400 shares of the biopharmaceutical company’s stock, valued at approximately $254,000. A number of other institutional investors have also recently added to or […]
Raymond James Financial Inc. purchased a new position in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 5,400 shares of the biopharmaceutical company’s stock, valued at approximately $254,000. A number of other institutional investors have also recently added to or […]
